Suppr超能文献

布地奈德鼻腔冲洗对合并哮喘的慢性鼻-鼻窦炎患者内镜鼻窦手术后的疗效

The Effectiveness of Budesonide Nasal Irrigation After Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Asthma.

作者信息

Kang Tae Wook, Chung Jae Ho, Cho Seok Hyun, Lee Seung Hwan, Kim Kyung Rae, Jeong Jin Hyeok

机构信息

Department of Otolaryngology-Head and Neck Surgery, Hanyang University School of Medicine, Seoul, Korea.

出版信息

Clin Exp Otorhinolaryngol. 2017 Mar;10(1):91-96. doi: 10.21053/ceo.2016.00220. Epub 2016 Jul 21.

Abstract

OBJECTIVES

Budesonide nasal irrigation was introduced recently for postoperative management of patients with chronic rhinosinusitis. The safety and therapeutic effectiveness of this procedure is becoming accepted by many physicians. The objective of this study was to evaluate the efficacy of postoperative steroid irrigation in patients with chronic rhinosinusitis and asthma.

METHODS

This prospective study involved 12 chronic rhinosinusitis patients with nasal polyps and asthma who received oral steroid treatment for recurring or worsening disease. The 22-item Sinonasal Outcomes Test (SNOT-22) and Lund-Kennedy endoscopy scores were checked before nasal budesonide irrigation, and 1, 2, 4, and 6 months after irrigation. We also calculated the total amount of oral steroids and inhaled steroids in the 6 months before irrigation and the 6 months after it.

RESULTS

The mean SNOT-22 score improved from 30.8±14.4 before irrigation to 14.2±8.7 after 6 months of irrigation (=0.030). The endoscopy score also improved from 7.4±4.7 before irrigation to 2.2±2.7 after 6 months (<0.001). The total amount of oral steroid was decreased from 397.8±97.6 mg over the 6 months before irrigation to 72.7±99.7 mg over the 6 months after irrigation (<0.001).

CONCLUSION

Nasal irrigation with budesonide is an effective postoperative treatment for chronic rhinosinusitis with asthma, which recurs frequently, reducing the oral steroid intake.

摘要

目的

布地奈德鼻腔冲洗最近被引入用于慢性鼻-鼻窦炎患者的术后管理。该操作的安全性和治疗效果正被许多医生所接受。本研究的目的是评估术后类固醇冲洗对慢性鼻-鼻窦炎合并哮喘患者的疗效。

方法

这项前瞻性研究纳入了12例患有鼻息肉和哮喘的慢性鼻-鼻窦炎患者,这些患者因疾病复发或加重接受了口服类固醇治疗。在进行布地奈德鼻腔冲洗前、冲洗后1个月、2个月、4个月和6个月时,检查22项鼻鼻窦结局测试(SNOT-22)和Lund-Kennedy内镜评分。我们还计算了冲洗前6个月和冲洗后6个月口服类固醇和吸入类固醇的总量。

结果

平均SNOT-22评分从冲洗前的30.8±14.4提高到冲洗6个月后的14.2±8.7(=0.030)。内镜评分也从冲洗前的7.4±4.7提高到冲洗6个月后的2.2±2.7(<0.001)。口服类固醇总量从冲洗前6个月的397.8±97.6毫克降至冲洗后6个月的72.7±99.7毫克(<0.001)。

结论

布地奈德鼻腔冲洗是治疗频繁复发的慢性鼻-鼻窦炎合并哮喘的一种有效的术后治疗方法,可减少口服类固醇的摄入量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a715/5327585/4ba5f7eebd2a/ceo-2016-00220f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验